{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T01:18:41Z","timestamp":1747358321705},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":730,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.jcf.2013.08.005","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T03:30:53Z","timestamp":1377747053000},"page":"37-42","source":"Crossref","is-referenced-by-count":7,"title":["Complicated Clostridium difficile colitis in children with cystic fibrosis: Association with gastric acid suppression?"],"prefix":"10.1016","volume":"13","author":[{"given":"G.","family":"Com","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.E.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.jcf.2013.08.005_bb0005","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile \u2014 more difficult than ever","volume":"359","author":"Kelly","year":"2008","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jcf.2013.08.005_bb0010","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1099\/0022-1317-50-8-720","article-title":"Colonisation and transmission of Clostridium difficile in healthy individuals examined by PCR ribotyping and pulsed-field gel electrophoresis","volume":"50","author":"Kato","year":"2001","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jcf.2013.08.005_bb0015","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1399-3062.2007.00269.x","article-title":"Clostridium difficile colitis in cystic fibrosis patients with and without lung transplantation","volume":"10","author":"Theunissen","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jcf.2013.08.005_bb0020","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2036.2009.04229.x","article-title":"Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection","volume":"31","author":"Turco","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jcf.2013.08.005_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1503\/cmaj.1040876","article-title":"Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case\u2013control studies","volume":"171","author":"Dial","year":"2004","journal-title":"CMAJ"},{"issue":"7","key":"10.1016\/j.jcf.2013.08.005_bb0030","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1503\/cmaj.060284","article-title":"Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy","volume":"175","author":"Dial","year":"2006","journal-title":"CMAJ"},{"issue":"23","key":"10.1016\/j.jcf.2013.08.005_bb0035","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1001\/jama.294.23.2989","article-title":"Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease","volume":"294","author":"Dial","year":"2005","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jcf.2013.08.005_bb0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0195-6701(03)00088-4","article-title":"Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea","volume":"54","author":"Cunningham","year":"2003","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jcf.2013.08.005_bb0045","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2036.2006.03015.x","article-title":"Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea","volume":"24","author":"Yearsley","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jcf.2013.08.005_bb0050","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1111\/j.1572-0241.2008.01975.x","article-title":"Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients","volume":"103","author":"Aseeri","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcf.2013.08.005_bb0055","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00431-003-1309-5","article-title":"Omeprazole, a proton pump inhibitor, improves residual steatorrhea in cystic fibrosis patients treated with high dose pancreatic enzymes","volume":"162","author":"Proesmans","year":"2003","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jcf.2013.08.005_bb0060","series-title":"Patient Registry Annual Data Report","year":"2011"},{"issue":"1","key":"10.1016\/j.jcf.2013.08.005_bb0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcf.2012.05.007","article-title":"Recurrent Clostridium difficile colitis in cystic fibrosis: an emerging problem","volume":"12","author":"Egressy","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2013.08.005_bb0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-3476(98)70511-6","article-title":"Severe Clostridium difficile-associated colitis in young patients with cystic fibrosis","volume":"132","author":"Rivlin","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2013.08.005_bb0075","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1399-3046.2010.01314.x","article-title":"Clostridium difficile colitis in children following lung transplantation","volume":"14","author":"Rosen","year":"2010","journal-title":"Pediatr Transplant"},{"issue":"5","key":"10.1016\/j.jcf.2013.08.005_bb0080","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society fo America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jcf.2013.08.005_bb0085","first-page":"1","article-title":"Epidemiology of community-associated Clostridium difficile infection, 2009 through","volume":"2013","author":"Chitnis","year":"2011","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jcf.2013.08.005_bb0090","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1136\/jcp.39.9.1013","article-title":"Asymptomatic carriage of Clostridium difficile in patients with cystic fibrosis","volume":"39","author":"Peach","year":"1986","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.jcf.2013.08.005_bb0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1542\/peds.2012-2992","article-title":"Policy statement: Clostridium difficile infection in infants and children","volume":"131","author":"DISEASES","year":"2013","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.jcf.2013.08.005_bb0100","doi-asserted-by":"crossref","first-page":"e4283","DOI":"10.1371\/journal.pone.0004283","article-title":"Mast cells and gastrointestinal dysmotility in the cystic fibrosis mouse","volume":"4","author":"DeLisle","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jcf.2013.08.005_bb0105","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/MPG.0b013e318219c397","article-title":"Impaired mucosal barrier function in the small intestine of the cystic fibrosis mouse","volume":"53","author":"De Lisle","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2013.08.005_bb0110","doi-asserted-by":"crossref","first-page":"341-e87","DOI":"10.1111\/j.1365-2982.2009.01418.x","article-title":"Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine","volume":"22","author":"De Lisle","year":"2010","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"10.1016\/j.jcf.2013.08.005_bb0115","first-page":"304","article-title":"Evidence of intestinal inflammation in patients with cystic fibrosis","volume":"51","author":"Werlin","year":"2010","journal-title":"JPGN"},{"issue":"9","key":"10.1016\/j.jcf.2013.08.005_bb0120","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archinternmed.2010.89","article-title":"Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection","volume":"170","author":"Howell","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcf.2013.08.005_bb0125","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ajg.2012.108","article-title":"Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis","volume":"107","author":"Kwok","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcf.2013.08.005_bb0130","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ajg.2012.179","article-title":"Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis","volume":"107","author":"Janarthanan","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcf.2013.08.005_bb0135","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/ajg.2012.213","article-title":"Mechanisms of increased gastroesophageal reflux in patients with cystic fibrosis","volume":"107","author":"Pauwels","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.jcf.2013.08.005_bb0140","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/gut.52.8.1159","article-title":"Molecular consequences fo cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas","volume":"52","author":"Ahmed","year":"2003","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jcf.2013.08.005_bb0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00005176-200207000-00017","article-title":"Ranitidine and omeprazole as adjuvant therapy to pancrelipase to improve fat absorption in patients with cystic fibrosis","volume":"35","author":"Francisco","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"11","key":"10.1016\/j.jcf.2013.08.005_bb0150","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00431-003-1309-5","article-title":"Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes","volume":"162","author":"Proesmans","year":"2003","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jcf.2013.08.005_bb0155","first-page":"CD003424","article-title":"Drug therapies for reducing gastric acidity in people with cystic fibrosis","volume":"4","author":"Ng","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.jcf.2013.08.005_bb0160","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1086\/520276","article-title":"Clostridium difficile-associated diarrhea","volume":"26","author":"Johnson","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcf.2013.08.005_bb0165","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1542\/peds.2010-2548","article-title":"Clinical report \u2014 probiotics and prebiotics in pediatrics","volume":"126","author":"Thomas","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2013.08.005_bb0170","article-title":"Gut Solutions to a Gut Problem: bacteriocins, probiotics and bacteriophage for control of Clostridium difficile infection","volume":"22","author":"Rea","year":"2013","journal-title":"J Med Microbiol"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199313001252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199313001252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T13:52:53Z","timestamp":1563803573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199313001252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1569199313001252"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2013.08.005","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}